Amantadine for chronic hepatitis c: a magic bullet or yet another dead duck?

Review

A Craxi et al. J Hepatol. 2001 Oct.

. 2001 Oct;35(4):527-30.

doi: 10.1016/s0168-8278(01)00184-2.

No abstract available

Comment on

Interferon plus amantadine versus interferon alone in the treatment of naïve patients with chronic hepatitis C: a UK multicentre study.
Caronia S, Bassendine MF, Barry R, Mills P, Naoumov NV, Fox R, Lowes J, Hollanders D, Murray-Lyon L, Irving WL, Goldin RD, Foster GR; UK Amantadine Study Group. Caronia S, et al. J Hepatol. 2001 Oct;35(4):512-6. doi: 10.1016/s0168-8278(01)00140-4. J Hepatol. 2001. PMID: 11682036 Clinical Trial.
Interferon and amantadine in combination as initial treatment for chronic hepatitis C patients.
Tabone M, Laudi C, Delmastro B, Biglino A, Andreoni M, Chieppa F, Bonardi R, Cariti G, Cusumano S, Brunello F, Calleri G, Manca A, Della Monica P, Sidoli L, Rizzetto M, Pera A. Tabone M, et al. J Hepatol. 2001 Oct;35(4):517-21. doi: 10.1016/s0168-8278(01)00166-0. J Hepatol. 2001. PMID: 11682037 Clinical Trial.

1. De Clercq E. Antiviral drugs: current state of the art. J Clin Virol. 2001;22:73–89. - PubMed
1. Wintermeyer S.M, Nahata M.C. Rimantadine: a clinical perspective. Ann Pharmacother. 1995;29:299–310. - PubMed
1. Smith J.P. Treatment of chronic hepatitis C with amantadine. Dig Dis Sci. 1997;42:1681–1687. - PubMed
1. Smith J.P. Hepatitis C treatment with amantadine-HCl in non-responders to alpha-interferon. Arq Gastroenterol. 1999;36:61–62. - PubMed
1. Tabone M, Ercole E, Zaffino C, Sallio Bruno F, Pera A, Bonino F. Amantadine hydrochloride decreases serum ALT activity without effects on serum HCV-RNA in chronic hepatitis C patients. Ital J Gastroenterol Hepatol. 1998;30:611–613. - PubMed